Goldman Sachs Group Inc Castle Biosciences Inc Transaction History

Goldman Sachs Group Inc

  • $605 Billion
  • Q3 2024

A detailed history of Goldman Sachs Group Inc transactions in Castle Biosciences Inc stock. As of the latest transaction made, Goldman Sachs Group Inc holds 242,800 shares of CSTL stock, worth $7.24 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
242,800
Previous 217,137 11.82%
Holding current value
$7.24 Million
Previous $4.73 Million 46.48%
% of portfolio
0.0%
Previous 0.0%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
BUY
$17.4 - $31.47 $446,536 - $807,614
25,663 Added 11.82%
242,800 $6.92 Million
Q2 2024

Aug 13, 2024
BUY
$18.84 - $24.94 $1.74 Million - $2.31 Million
92,465 Added 74.17%
217,137 $4.73 Million
Q1 2024

May 15, 2024
BUY
$18.06 - $25.3 $799,750 - $1.12 Million
44,283 Added 55.09%
124,672 $2.76 Million
Q4 2023

Feb 13, 2024
SELL
$12.19 - $22.43 $869,902 - $1.6 Million
-71,362 Reduced 47.03%
80,389 $1.73 Million
Q3 2023

May 14, 2024
BUY
$13.28 - $20.3 $947,687 - $1.45 Million
71,362 Added 88.77%
151,751 $2.56 Million
Q3 2023

Nov 14, 2023
BUY
$13.28 - $20.3 $929,998 - $1.42 Million
70,030 Added 85.69%
151,751 $2.56 Million
Q2 2023

May 14, 2024
SELL
$11.66 - $26.0 $655,210 - $1.46 Million
-56,193 Reduced 40.74%
81,721 $1.12 Million
Q2 2023

Aug 14, 2023
SELL
$11.66 - $26.0 $655,210 - $1.46 Million
-56,193 Reduced 40.74%
81,721 $1.12 Million
Q1 2023

May 14, 2024
SELL
$19.47 - $28.49 $2.12 Million - $3.1 Million
-108,942 Reduced 44.13%
137,914 $3.13 Million
Q1 2023

May 11, 2023
SELL
$19.47 - $28.49 $2.12 Million - $3.1 Million
-108,942 Reduced 44.13%
137,914 $3.13 Million
Q4 2022

May 14, 2024
BUY
$18.08 - $30.0 $1.16 Million - $1.93 Million
64,184 Added 35.14%
246,856 $5.81 Million
Q4 2022

Feb 13, 2023
BUY
$18.08 - $30.0 $1.16 Million - $1.93 Million
64,184 Added 35.14%
246,856 $5.81 Million
Q3 2022

May 14, 2024
BUY
$22.51 - $34.32 $1.42 Million - $2.16 Million
62,987 Added 52.63%
182,672 $4.76 Million
Q3 2022

Nov 10, 2022
BUY
$22.51 - $34.32 $1.42 Million - $2.16 Million
62,987 Added 52.63%
182,672 $4.76 Million
Q2 2022

May 14, 2024
BUY
$16.0 - $45.99 $628,736 - $1.81 Million
39,296 Added 48.88%
119,685 $2.63 Million
Q2 2022

Aug 15, 2022
BUY
$16.0 - $45.99 $903,408 - $2.6 Million
56,463 Added 89.31%
119,685 $2.63 Million
Q1 2022

May 16, 2022
SELL
$33.17 - $46.98 $271,529 - $384,578
-8,186 Reduced 11.46%
63,222 $2.84 Million
Q4 2021

Feb 14, 2022
SELL
$39.06 - $67.58 $6.1 Million - $10.5 Million
-156,106 Reduced 68.61%
71,408 $3.06 Million
Q3 2021

Nov 10, 2021
BUY
$60.13 - $77.6 $13.7 Million - $17.7 Million
227,514 New
227,514 $15.1 Million

Others Institutions Holding CSTL

# of Institutions
202
Shares Held
26M
Call Options Held
303K
Put Options Held
30.3K
View Full List

About CASTLE BIOSCIENCES INC

CSTL Quotes by TradingView
  • Ticker CSTL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 26,297,000
  • Market Cap $784M
  • Description
  • Castle Biosciences, Inc., a commercial-stage diagnostics company, focuses to provide diagnostic and prognostic testing services for dermatological cancers. Its lead product is DecisionDx-Melanoma, a multi-gene expression profile (GEP) test to identify the risk of metastasis for patients diagnosed with invasive cutaneous melanoma. The company als...
More about CSTL
Track This Portfolio

Track Goldman Sachs Group Inc Portfolio

Follow Goldman Sachs Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Goldman Sachs Group Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email